Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection

BACKGROUND: Novel drugs for Clostridium difficile (C. difficile) infections have been proven to reduce recurrent infections. Because of their high financial costs, identification of patients at high risk for recurrence is essential to provide optimal treatment. The ATLAS score’s ability to predict 9...

Descripción completa

Detalles Bibliográficos
Autores principales: Knafl, Daniela, Vossen, Matthias G., Gerges, Christian, Lobmeyr, Elisabeth, Karolyi, Mario, Wagner, Ludwig, Thalhammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394683/
https://www.ncbi.nlm.nih.gov/pubmed/30617709
http://dx.doi.org/10.1007/s00508-018-1432-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394683/
https://www.ncbi.nlm.nih.gov/pubmed/30617709
http://dx.doi.org/10.1007/s00508-018-1432-y

Ejemplares similares